0000816956 false 0000816956 2020-03-19 2020-03-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15 (d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): March 19, 2020

 

CONMED CORPORATION

(Exact name of registrant as specified in its charter)

 

New York   0-16093   16-0977505
(State or other jurisdiction of   (Commission   (I.R.S. Employer
incorporation or organization)   File Number)   Identification No.)

 

525 French Road

Utica, New York 13502

(Address of principal executive offices, including zip code)

 

(315) 797-8375

(Registrant's telephone number, including area code)

 

Securities registered pursuant to Rule 12(b) of the Act

 

Title of each class   Trading Symbol   Name of each exchange on which
registered
         
Common Stock, $0.01 par value   CNMD   NYSE

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (See General Instruction A.2 below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

Item 8.01 Other Events.

As a result of the escalating COVID-19 (coronavirus) pandemic, CONMED Corporation is withdrawing its previously issued first quarter and full-year 2020 financial guidance.  The Company’s prior financial guidance was based on the estimated impact as of the date of issuance, March 10, 2020.  At that time, the impact of COVID-19 was principally confined to Asia and Europe.  In recent days, the pandemic has expanded further into Europe and the United States, limiting the Company’s ability to estimate the specific impact on its business operations or financial results for the first quarter and full-year 2020.  The Company anticipates that it may experience material disruption to its financial results for the first quarter and full-year 2020 as a result of the ongoing spread of COVID-19.    

 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

The following exhibit is included herewith:

  Exhibit No. Description
     
  104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

 

 

 

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  CONMED CORPORATION
  (Registrant)
   

 

 

 

  By: /s/ Todd W. Garner
  Name: Todd W. Garner
  Title: Executive Vice President, Chief Financial Officer

 

Date: March 19, 2020

 

 

 

CONMED (NASDAQ:CNMD)
Historical Stock Chart
Von Dez 2024 bis Jan 2025 Click Here for more CONMED Charts.
CONMED (NASDAQ:CNMD)
Historical Stock Chart
Von Jan 2024 bis Jan 2025 Click Here for more CONMED Charts.